Clinical Trials Browser

Thyroid Neoplasms × pembrolizumab × 90 days × Clear all

NCT03360890 2026-03-13

iPRIME

Phase 2 Active not recruiting

Salivary Gland Neoplasms, Thyroid Neoplasms

NCT07419932 2026-02-19

NeoLATC

Thyroid Neoplasms

NCT05119296 2025-12-22

Phase II Trial of Pembrolizumab in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer

Phase 2 Active not recruiting

Thyroid Neoplasms